Mai Tahboub

Senior Contracts Specialist at Fortrea

Mai Tahboub is a Senior Contracts Specialist at Fortrea since October 2021, specializing in the preparation and negotiation of Clinical Trial Agreements across multiple European countries. Prior to this, Mai held multiple roles at Labcorp Drug Development from May 2017 to September 2021, advancing from Site Contracts Specialist I to Site Contracts Specialist II. Mai's diverse experience includes working as a Parliamentary Development Officer at the United Nations, managing parallel projects and leading a distributed team, and serving as an MdB Assistant at the Deutscher Bundestag, where research and citizen engagement were key responsibilities. Academic credentials include a Master of Laws in Pharma Law from The Philipp University of Marburg, a Master's Degree in Public Policy and Good Governance from Universität Passau, and a Bachelor's Degree in Law from Birzeit University.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Fortrea

13 followers

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.